4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0001209191-23-051408
EVP and Chief Legal Officer sold 610 shares at $346.76 ($211,524)
- EVP and Chief Legal Officer gave up 408 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Biller Jonathan · EVP and Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-29 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −408 | $350.72 | $143,094 | 11,179 | D |
| 2023-10-02 | Sale : show line 2 in the form 10b5-1 | −610 | $346.76 | $211,524 | 10,569 | D |
| Open-market sales · 610 sh · avg $346.76 · $211,524 | ||||||
Loading xslF345X05/doc4.xml…